AU5591200A - 49 human secreted proteins - Google Patents

49 human secreted proteins

Info

Publication number
AU5591200A
AU5591200A AU55912/00A AU5591200A AU5591200A AU 5591200 A AU5591200 A AU 5591200A AU 55912/00 A AU55912/00 A AU 55912/00A AU 5591200 A AU5591200 A AU 5591200A AU 5591200 A AU5591200 A AU 5591200A
Authority
AU
Australia
Prior art keywords
secreted proteins
human secreted
human
proteins
secreted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU55912/00A
Inventor
George A. Komatsoulis
Craig A Rosen
Steven M. Ruben
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of AU5591200A publication Critical patent/AU5591200A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU55912/00A 1999-06-11 2000-06-01 49 human secreted proteins Abandoned AU5591200A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13863099P 1999-06-11 1999-06-11
US60138630 1999-06-11
PCT/US2000/014973 WO2000077026A1 (en) 1999-06-11 2000-06-01 49 human secreted proteins

Publications (1)

Publication Number Publication Date
AU5591200A true AU5591200A (en) 2001-01-02

Family

ID=22482899

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55912/00A Abandoned AU5591200A (en) 1999-06-11 2000-06-01 49 human secreted proteins

Country Status (5)

Country Link
EP (1) EP1192176A4 (en)
JP (1) JP2003502062A (en)
AU (1) AU5591200A (en)
CA (1) CA2383041A1 (en)
WO (1) WO2000077026A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030232056A1 (en) 1999-09-10 2003-12-18 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer
US6710170B2 (en) 1999-09-10 2004-03-23 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer
AU6531101A (en) * 2000-06-02 2001-12-17 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2001293107A1 (en) * 2000-09-25 2002-04-02 Millennium Pharmaceuticals, Inc. 32612, a novel human peptide transporter and uses therefor
AU2002214021A1 (en) 2000-10-16 2002-04-29 Bayer Aktiengesellschaft Regulation of human serine-threonine protein kinase
US7157558B2 (en) 2001-06-01 2007-01-02 Genentech, Inc. Polypeptide encoded by a polynucleotide overexpresses in tumors
AR059900A1 (en) 2006-03-17 2008-05-07 Genentech Inc ANTI-TAT226 ANTIBODIES AND IMMUNOCATE PLAYERS
CA2676790A1 (en) * 2007-02-22 2008-08-28 Genentech, Inc. Methods for detecting inflammatory bowel disease
CA2689681C (en) * 2009-01-21 2017-08-29 Massachusetts Institute Of Technology Compositions and methods for assessing cytotoxicity of single cells
ES2816647T3 (en) * 2012-01-17 2021-04-05 Univ Leland Stanford Junior High affinity SIRP-alpha reagents
KR101782634B1 (en) * 2015-06-29 2017-10-25 주식회사 큐라클 Decoy Peptides Inhibiting binding of AMIGO2 and 3-phosphoinositide-dependent kinase 1
GEP20217326B (en) 2015-08-07 2021-11-25 Alx Oncology Inc Constructs having a sirp-alpha domain or variant thereof
CN109030796B (en) * 2018-06-26 2024-07-30 山东卓越生物技术股份有限公司 Medical test card and test device thereof
EP3833690B1 (en) 2018-08-08 2024-03-27 ImmuneOnco Biopharmaceuticals (Shanghai) Inc. Recombinant bifunctional protein targeting cd47 and her2
JP2022534212A (en) 2019-05-31 2022-07-28 エーエルエックス オンコロジー インコーポレイテッド Methods of treating cancer with SIRP alpha FC fusions in combination with immune checkpoint inhibitors
US12098214B2 (en) 2021-05-13 2024-09-24 ALX Oncology Inc. Combination therapies for treating cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998054963A2 (en) * 1997-06-06 1998-12-10 Human Genome Sciences, Inc. 207 human secreted proteins
JP2001518793A (en) * 1997-04-10 2001-10-16 ジェネティックス・インスチチュート・インコーポレーテッド Secretory expression sequence tags (sESTs)

Also Published As

Publication number Publication date
JP2003502062A (en) 2003-01-21
EP1192176A4 (en) 2003-03-05
CA2383041A1 (en) 2000-12-21
WO2000077026A8 (en) 2001-03-29
WO2000077026A1 (en) 2000-12-21
EP1192176A1 (en) 2002-04-03

Similar Documents

Publication Publication Date Title
AU1473501A (en) 21 human secreted proteins
AU1438001A (en) 27 human secreted proteins
AU1604401A (en) 18 human secreted proteins
AU1448701A (en) 15 human secreted proteins
AU5591200A (en) 49 human secreted proteins
AU4200900A (en) 49 human secreted proteins
AU3769700A (en) 45 human secreted proteins
AU2757500A (en) 33 human secreted proteins
AU1918601A (en) 23 human secreted proteins
AU3517000A (en) 50 human secreted proteins
AU1916101A (en) 19 human secreted proteins
AU3628600A (en) 46 human secreted proteins
AU3765500A (en) 50 human secreted proteins
AU4074500A (en) 49 human secreted proteins
AU3208700A (en) 33 human secreted proteins
AU3249300A (en) 47 human secreted proteins
AU3396600A (en) 49 human secreted proteins
AU1449001A (en) 28 human secreted proteins
AU1472801A (en) 24 human secreted proteins
AU3766800A (en) 48 human secreted proteins
AU3767300A (en) 47 human secreted proteins
AU3871300A (en) 50 human secreted proteins
AU3628700A (en) 49 human secreted proteins
AU1655701A (en) 15 human secreted proteins
AU3730500A (en) 50 human secreted proteins

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase